Optimizing respiratory care: clinical pharmacist interventions in respiratory tract infection management at a tertiary teaching hospital

Submitted: January 6, 2025
Accepted: January 17, 2025
Published: March 20, 2025
Abstract Views: 299
PDF_EARLY VIEW: 96
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Respiratory tract infections (RTIs) are prevalent in India, affecting approximately 11.3% of the population. India leads globally in lung disease mortality, including chronic obstructive pulmonary disease and asthma, contributing significantly to disability-adjusted life years and mortality rates. The role of clinical pharmacist interventions (CPIs) in optimizing antibiotic use and managing RTIs is increasingly recognized as vital for improving patient outcomes and reducing healthcare costs. This study aimed to evaluate the effectiveness of CPIs in managing RTIs among inpatients at Vivekananda General Hospital, Hubballi, and to identify common drug-related problems (DRPs) using the Hepler-Strand classification system. A cross-sectional study was conducted over 6 months, including 200 inpatients diagnosed with RTIs. Data was collected through patient profiles, treatment charts, and medical case sheets. The study employed descriptive and inferential statistical analyses to evaluate the impact of CPIs on antibiotic therapy and the prevalence of DRPs. The study identified drug-drug interactions as the most frequent DRP (38.30%), followed by drug duplication (31.49%) and improper drug selection (9.79%). Other issues included adverse drug reactions (4.68%), overdosage (5.53%), untreated indications (6.38%), subtherapeutic dosage (2.13%), and drug use without indication (1.70%). CPIs, including prospective audits, prescription feedback, and healthcare professional education, effectively addressed these issues, improved antibiotic appropriateness, and optimized patient outcomes. CPIs significantly enhance the management of RTIs by addressing various DRPs and optimizing antibiotic use. The study underscores the importance of incorporating pharmacists into antimicrobial stewardship programs to improve medication safety, efficacy, and overall patient care in managing RTIs. Continued emphasis on pharmacist-led interventions and adherence to best practices in antimicrobial stewardship is essential for reducing the burden of respiratory diseases in India.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Sharma BB, Singh J, Patel R, et al. Proportionate clinical burden of respiratory diseases in Indian outdoor services and its relationship with seasonal transitions and risk factors: the results of SWORD survey. PLoS One 2022;17:e0268216. DOI: https://doi.org/10.1371/journal.pone.0268216
Ghoshal A, Salvi S, Agrawal A, Gupta D, et al. The burden of segregated respiratory diseases in India and the quality of care in these patients: results from the Asia-Pacific Burden of Respiratory Diseases study. Lung India 2016;33:611-9. DOI: https://doi.org/10.4103/0970-2113.192878
Shen J, Sun Q, Zhou X, et al. Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital. Int J Clin Pharm 2011;33:929-33. DOI: https://doi.org/10.1007/s11096-011-9577-z
Dawaiwala I, Raut S, Fuse M, et al. Antimicrobial stewardship and clinical pharmacist interventions in an Indian tertiary care hospital. J Am Coll Clin Pharm 2024;7:46-54. DOI: https://doi.org/10.1002/jac5.1885
Alsayed AR, Almutairi R, Alharbi M, et al. Validation of an assessment, medical problem-oriented plan, and care plan tools for demonstrating the clinical pharmacist’s activities. Saudi Pharm J 2022;30:1464-72. DOI: https://doi.org/10.1016/j.jsps.2022.07.007
Divya G, Manohar R YV, Reddy MN, et al. Heralding the drug related problems by using Hepler-Strand classification in a tertiary care teaching hospital. Glob J Pharmaceu Sci 2020;7:555725. DOI: https://doi.org/10.19080/GJPPS.2020.07.555725
Hasan MM, Sasha KK, Yunus RM, Alam K. Prevalence of acute respiratory infections among children in India: Regional inequalities and risk factors. Matern Child Health J 2022;26:1594-602. DOI: https://doi.org/10.1007/s10995-022-03424-3
Li X, Cao X, Guo M, et al. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ 2020;368:m234. DOI: https://doi.org/10.1136/bmj.m234
Nasr ZG, Elamin W, Basil M, Eljaaly K. Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review. Int J Clin Pharm 2023;45:613-21. DOI: https://doi.org/10.1007/s11096-023-01574-0

Ethics Approval

The KLE College of Pharmacy Ethical Committee gave its approval to the study. IEC Reference Number: KLECOPH/IEC/2023-24/08.

How to Cite

Patil, Chandrashekhar Mallikarjun, Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Vinod Ashok Koujalagi, Agadi Hiremath Viswanatha Swamy, and Sanatkumar Bharamu Nyamagoud. 2025. “Optimizing Respiratory Care: Clinical Pharmacist Interventions in Respiratory Tract Infection Management at a Tertiary Teaching Hospital”. Monaldi Archives for Chest Disease, March. https://doi.org/10.4081/monaldi.2025.3337.

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.